Vivos Therapeutics (VVOS) Misses Q2 EPS by 60c
Vivos Therapeutics (NASDAQ: VVOS) reported Q2 EPS of ($0.60). Revenue for the quarter came in at $4.1 million.
For earnings history and earnings-related data on Vivos Therapeutics (VVOS) click here.
Vivos Therapeutics (NASDAQ: VVOS) reported Q2 EPS of ($0.60). Revenue for the quarter came in at $4.1 million.
For earnings history and earnings-related data on Vivos Therapeutics (VVOS) click here.